Patent cliff continues to drive mergers in drug industry
March 30, 2015 at 14:50 PM EDT
A rash of mergers among pharmaceutical companies is driven by fears that a lack of innovation among drug makers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|